Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer

Feng, Y., Chen, C., Shao, A., Wu, L., Hu, H., & Zhang, T. (2024). Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer. Acta Pharmaceutica Sinica B, 14(12), 5091–5105. https://doi.org/10.1016/j.apsb.2024.09.008
Authors:
Yifan Feng
Chengjuan Chen
Lei Wu
Haiyu Hu
Tiantai Zhang
Anqi Shao
Affiliated Authors:
Anqi Shao
Columbia Affiliation:
Author Keywords:
autoimmune diseases
cancer
degraders
il-1r/tlrs signal pathway
irak4
irak4 inhibitors
nf-κb
nf-kb
elink
Publication Type:
Article
Unique ID:
10.1016/j.apsb.2024.09.008
PMID:
39807338
DOI:
10.1016/j.apsb.2024.09.008
Journal:
Acta Pharmaceutica Sinica B
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record
View PubMed Record

Record Created: